COMP <GO>
AXGN vs LIVN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Axogen Inc. (NASDAQ) VS. LivaNova PLC (NASDAQ) • 15-METRIC TALLY: AXGN 5
— LIVN 5
■ METRIC PARITY
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
options-implied-move
—
LAST: $81.25 (+0.73%) • MKT CAP: $4.48B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AXGN VS. LIVN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AXGN | LIVN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.30% | 67.70% | +6.60 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.60% | 17.30% | -19.90 | LIVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.10% | 3.87% | -3.97 | LIVN | /fcf-yield <GO> |
| Operating Margin | -3.50% | 14.40% | -17.90 | LIVN | /operating-margins <GO> |
| Net Profit Margin | -7.00% | -17.50% | +10.50 | AXGN | /net-margins <GO> |
| Revenue Growth (YoY) | 20.20% | 10.70% | +9.50 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 18.64 | 2.21 | +16.43 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | LIVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.3 | 58.2 | +16.10 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.96B | $4.48B | -$1.51B | LIVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AXGN REV | LIVN REV | AXGN GROSS % | LIVN GROSS % | AXGN FCF | LIVN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $225.2M | $1.39B | 74.3% | 67.7% | -$2.9M | $173.3M |
| FY 2024 | $187.3M | $1.25B | 75.8% | 68.1% | $1.4M | $135.9M |
| FY 2023 | $159.0M | $1.15B | — | — | -$12.9M | $74.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AXGN // BETA 1.10
LIVN // BETA —